GCG and Cognitive impairment: Moreover, chronic oral galactose administration was found to prevent the development of cognitive deficits in an animal model by stimulation of endogenous glucagon-like peptide 1 (GLP1)-mediated normalization of cerebral glucose hypometabolism, thus ameliorating neurodegenerative disorder [33].